Hematopoietic stem cells (HSCs) play a key role in hematopoietic system that functions mainly in homeostasis and immune response. HSCs transplantation has been applied for the treatment of several diseases. However, HSCs persist in the small quantity within the body, mostly in the quiescent state. Understanding the basic knowledge of HSCs is useful for stem cell biology research and therapeutic medicine development. Thus, this paper emphasizes on HSC origin, source, development, the niche, and signaling pathways which support HSC maintenance and balance between self-renewal and proliferation which will be useful for the advancement of HSC expansion and transplantation in the future.
1. Introduction
Hematopoietic stem cells (HSC) are adult stem cells that contain the potentiality in self-renew and differentiation into specialized blood cells that function in some biological activities: control homeostasis balance, immune function, and response to microorganisms and inflammation. HSCs can also differentiate into other specialized cell or so called plasticity such as adipocytes [1], cardiomyocytes [2], endothelial cells [3], fibroblasts/myofibroblasts [4], liver cells [5, 6], osteochondrocytes [7, 8], and pancreatic cells [9]. Most HSCs are in quiescent state within the niches that maintain HSC pool and will respond to the signals after the balance of blood cells or HSC pool is disturbed from either intrinsic or extrinsic stimuli.
In addition, HSCs have been studied extensively, especially, for the therapeutic purposes in the treatment of blood diseases, inherited blood disorders, and autoimmune diseases. Nonetheless, advanced development in this field needs knowledge in the biological studies as a background in performing strategy and maintaining of HSCs. Thus, HSC source, origin, niches for HSC pool, and signaling pathways, essential for the regulation of HSCs, will be discussed in this review.
2. HSCs Origin and Development
In the hematopoietic system, the discovery of HSCs has shed the light on stem cell biology studies including connection to other adult stem cells through the basic concepts of differentiation, multipotentiality, and self-renewal. In the early period of those discoveries, lethally irradiated animals were found to be rescued by spleen cells or marrow cells [17, 18]. After mouse bone marrow cells were transplanted into irradiated mice, the clonogenic mixed colony of hematopoietic cells (often composed of granulocyte/megakaryocyte and erythroid precursors) were formed within the spleen, which these colonies were then termed colony-forming unit spleen (CFU-S) [19]. Some colonies of primary CFU-S could reconstitute hematopoietic system in the secondary irradiated mice after receiving transplantation [20]. Initially, CFU-S was first proposed that it may be differentiated from HSC, but subsequently, CFU-S was demonstrated to be originated from more committed progenitor cells [21]. The discovery by Till and McCulloch embarked on a new journey toward many investigations to clarify HSC biology, functional characterization, purify, cultivation, and other stem cells research.
Hematopoiesis and HSC development are the key role to improve efficient HSC expansion for the transplantations. Embryogenesis study has been performed to identify HSC origin and activity from various anatomical sites of several kinds of animals such as zebrafish, chicken, and mouse including human embryos model have been emerging. Initially, Moore and Metcalf showed that hematopoietic cells in the yolk sac could generate hematopoietic progenitors that restricted to only erythroid and myeloid lineages [22]. Moreover, the Runx1 (transcription factor for the onset of definitive hematopoiesis) was first identified to express at embryonic day 7.5 (E7.5) in the yolk sac, the chorionic mesoderm, and parts of allantoic mesoderm [23]. However, HSCs found in the yolk sac lacked the definitive hematopoietic stem cells which did not show long-term hematopoietic reconstitution activity in mouse embryo prior to E11.5 [24]. On the other hand, long-term repopulating HSCs (LT-HSCs) were shown to increase largely in the aorta-gonad mesonephros (AGMs) region of the mouse embryo including the serially transplantable irradiated mice, suggesting that AGM region is the first site for HSCs detection [24, 25]. Vitelline and umbilical arteries were also endowed with hematopoietic potential [26]. The presence of HSC phenotype in the embryo was supported by the evidence that a high number of nonerythroid progenitors with high-proliferative potential was observed from which the liver rudiment has been removed [27]. A dense population of CD34+ cells adhering to the ventral side of the aortic endothelium within the embryonic compartment was shown to display a cell-surface and molecular phenotype of primitive hematopoietic progenitors (CD45+, CD34+, CD31+, CD38-, negative for lineage markers, GATA-2+, GATA-3+, c-myb+, SCL/TAL1+, c-kit+, flk-1/KDR+) [28, 29]. Moreover, the autonomously emergence of myelolymphoid lineage from progenitors was found in splanchnopleural mesoderm and derived aorta within the human embryo proper, while restricted progenitors were generated in the yolk sac [30]. Altogether, AGM region in the embryo is suggested as the source of definitive hematopoiesis as the generation occurs between E10.5 and E12.0 with the enhance activity of HSC after mid-day 11 of gestation [10, 31–33]. Even though, the main source of fetal hematopoiesis was considered in AGM including vitelline and umbilical arteries, the question is raised whether the rare population produced in those regions would be enough for the distribution into fetal liver for alternative development of enormous HSCs before the transition of hematopoiesis continues to occur in the fetal thymus and bone marrow in postnatal life. Recently, the placenta, an extraembryonic organ, has been considered as the other hematopoietic organ for de novo hematopoiesis [34, 35]. This may be due to the physiology of the placenta containing highly vascularized blood vessels, and cytokines and growth factors rich environment for proper microenvironment of hematopoiesis and development [36]. Additionally, privilege site within the placenta may hide the HSCs from the promoting signal into differentiation stage. However, there is no experimental evidence to support that HSCs are generated de novo in the extraembryonic tissues. Therefore, future works will be needed to elucidate this enigma. Summarization of the source of blood cells during gestation through adult life has been elucidated in Figure 1.
Source of blood cells during gestation through after birth. Intraembryonic yolk sac is the first site of blood cells observation at around E7.0–E7.5. The de novo hematopoiesis in the placenta and AGM occurs at nearly similar wave of gestation (around E8.5–E10.5) beforeit circulates into fetal liver where there is the large HSC pool during gestation. At around E16.5, the HSCs migrate and reside within the bone marrow which finally becomes the source of HSC in adult life (adapted from [10]).
The origin of HSC in the placenta is being questioned. Understanding how theplacenta develops might be useful to define the source and the niches supporting HSC development. Mouse and human placentas are anatomically similar and its genes have analogous identity [37, 38]. The placenta is formed from trophectoderm, mesodermal tissues, chorionic mesoderm, and allantois (Figure 2) [39]. At E8.5 of mouse gestation, the allantois develops and fuses with chorionic mesoderm through its distal part generating the chorioallantoic mesenchyme in the chorionic plate and continuing to form the fetal vascular compartment of the placental labyrinth, while the proximal part becomes the umbilical cord [11].
Mouse placenta development. (a) At E3.5 of early embryogenesis, blastocyst is formed, containing inner cell mass located at one side of the blastocoelic cavity and outer layer (trophectodermal epithelium) which give rise to the placenta. (b) Between E7.5–E8.25 mesodermal precursors originating from the primitive streak grow into the allantois (light grey) which then develops toward the ectoplacental cone (dark grey). (c) Chorioallantoic fusion between the allantoic and chorionic mesoderm at E8.5. After that, Chorionic villi and vasculature are formed producing and generates extensive villous branching called labyrinth. (d) At E11.5, umbilical cord is fully formed to connect the placenta with fetus where fetomaternal bloods circulate. (e) Cross-section of the placenta at E12.5 showing the chorioallantoic mesenchyme lies cover the placenta labyrinth with fetal vessels lined by fetal endothelium (dark vessels with lumen) and trophoblast lined by maternal blood spaces (grey vessels surrounded by dark trophoblasts). al, allantois; ch, chorion; am, amnion; epc, ectoplacental cone; ys, yolk sac; psp, para-aortic splanchnopleura; da, dorsal aorta; ua, umbilical artery; va, vitelline artery; fl, fetal liver (modified from [11]).
E3.5
˂E8.5
E9.0
E11.5
E12.5
The umbilical cord (a constitution of the fetal arteries and veins that inserted within chorionic plate of the placenta) is attached to the center of fetal surface for uteroplacenta circulation through maternal blood. Maternal blood passes through the placenta from uterine arteries to spiral arteries in the maternal decidua. Thereafter, the maternal blood percolates through the villous tree in humans (or the labyrinth in mice) known as chorionic villi which created and lined by fetal trophoblast cells [37, 39]. The inner core of the chorionic villi consists of allantoic mesenchyme and vasculature which is continuous with that of the umbilical cord. The chorioallantoic vasculature connects the placenta via the dorsal aorta and fetal liver through the umbilical cord vessels. These regions are localized by an equally dense network of fetal capillaries where the fetomaternal exchange occurs [37].
Because of the mesoderm layer gives rise to all blood cells, the chorionic and allantoic mesoderms are considered as the origin of HSC in the placenta. This can be explained by the observation that hematopoietic potential emerging from both tissues and has been identified with myeloerythroid potential [40]. In addition, hematopoietic cells (CD34+CD45+) collected from placental villi stroma and highly expression of CD45+ cells that appear to be budding from the vasculature have been found from human placenta during midgestation [35]. Moreover, cells harvested from term human placenta vessels and tissues could generate human hematopoietic repopulation of nonobese diabetic (NOD)-SCID mice, which harbored and/or amplified in vascular labyrinth placenta niche [35]. These observations imply that the placenta is the HSC source along with umbilical cord blood. At E10.5, first HSC emerge in the dorsal aorta before the onset of heart beat where the circulation has not been formed. One study showed that in the absence of heat beat in Ncx1 (the sodium and calcium exchange pump1) knockout embryos, the HSC development was verified to initiate in the placental vasculature [41]. Additionally, multilineage hematopoietic potential could be obtained from placentas of Ncx1 knockout embryos. Thus, within the extraembryonic tissues, fetal HSCs were observed in placenta, vitelline, and umbilical arteries.
The true origin of HSC in the intraembryonic hematopoiesis remains controversial. One of the main hypotheses is hemangioblasts or hemogenic endothelial while the alternative model is mesodermal precursors. The blood islands originated in the yolk sac are derived from mesodermal cell aggregates, which contain the ability to differentiate into both hematopoietic and endothelial cells. The common precursor by those lineages is suggested to be so called the hemangioblast [42]. Hematopoietic phenotype originated from hemogenic endothelium has been found in avian and mouse during ontogeny [43, 44]. Imaging and cell-tracking study explored that hemogenic endothelial cells could give rise to hematopoietic cells [45]. By time-lapse imaging study in single-cell mouse mesodermal cells demonstrated that it could generate endothelial sheet colonies and some colonies developed the hematopoietic morphology that upregulating the blood-specific proteins CD45, CD41, and CD11b and losing their intact morphology. Recently, this evidence has been supported by the observation on time-lapse confocal imaging from live mouse aorta showing that HSCs (Sca+, c-kit+, CD41+) could emerge directly from ventral aortic endothelial cells [46]. Moreover, Oberlin and colleagues proved that the origin of adult bone marrow HSCs which most of them derived were from the vascular endothelial-cadherin ancestor [47]. Taken together, these studies pinpoint the evidence that definitive hematopoietic stem and progenitor cells emerge from the hemogenic endothelium at the AGM region.
3. HSC Niches
Homing of HSC from other definitive hematopoiesis to fetal bone marrow is thought to involve some signaling factors such as stromal derived factor-1 (SDF-1 or CXCL12)/chemokine C-X-C receptor 4 (CXCR4) axis [48, 49]. Soluble factors are not only mediated in fetal bone marrow but also in adult bone marrow to maintain HSC in undifferentiated state and regulate HSC in proliferative and differentiated states within the specific microenvironments termed “niche” throughout the life [12]. Stem cell niche was first proposed by Schofield [21], with the later identification in Drosophila melanogester’s ovary to confirm the existence of HSC niche [50]. Germline stem cells resided in the Drosophila ovary that is surrounded by differentiated somatic cells have been shown to be essential for maintaining stem cells survival and division [50]. Thus, HSC niche is the special local environments of HSCs that maintains and controls HSCs function by regulating survival, self-renewal ability, and cell fate decision. Such molecules have been identified to be associated with HSC homing to bone marrow, for example, SDF1-α, β1-integrins, metalloproteinases (MMP), and serine-threonine protein phosphatase (PP)2A [51, 52]. By using real-time imaging, it is possible to explore the localization of HSCs with their function [53]. HSCs lodge in the endosteal surface, osteoblasts, and blood vessels, particularly in trabecular regions, in the mouse calvaria. On the contrary, more mature cells reside away from the endosteum. Similarly, a study by developed ex vivo real-time imaging in irradiated mice show the homing and lodgment of transplantable HSCs in the endosteal region of the trabecular bone area where they respond to bone marrow damage by rapidly dividing [54].
Recently HSCs niches are suggested to be mediated in two main microenvironments within bone marrow: endosteal niche and vascular niche (Figure 3). First, endosteal niche: osteoblasts derived from mesenchymal precursors are localized in the endosteal regions which are well vascularized. The activation of osteoblastic differentiation is in part mediated by HSC-derived bone morphogenic protein-2 (BMP-2) and BMP-6 [55]. Osteoblasts are suggested as the niche due to the finding that the number of osteoblasts is increased from parathyroid hormone activation and results in an increase HSCs number in vivo [56]. This signal was found to be activated through Jagged1, a serrate family of Notch ligand, on osteoblasts [57]. Study by Chitteti and colleagues supports this evidence and shows that enhancing hematopoiesis promoted by osteoblast via Notch signaling not only through Jagged1 upregulation, but also Notch2, Jagged2, Delta1 and 4, Hes1 and 5, and Deltex ligands [58]. Soluble factors produced from osteoblasts function in regulating HSC quiescence, HSC pool and fate such as angiopoietin-1 (Ang-1) [59], SDF-1 (CXCL12) [60], and osteopontin [61]. Recently, osteoblasts secreted cysteine protease cathepsin X have been found to catalyze the chemokine CXCL-12, a potent chemoattractive cytokine for HSCs, and ablate the attachment of CD34+ cells with the osteoblasts [62]. This result suggests the role of osteoblasts in regulate HSCs trafficking in the bone marrow.
Candidate cellular niches mediated in maintenance and regulation of HSCs in bone marrow; endosteal and vascular niches. HSCs are in contact with SNO cells, bone-lining osteoblasts, within endosteal niche. Osteblasts produce several signal molecules such as Notch ligands, angiopoietin-1 (Ang-1), CXCL12, and cathepsin X mediated in control HSC pool and maintenance. Most HSCs are found in sinusoids, particularly adherence to CAR cells that surround sinusoidal endothelial cells (reticular niche). Similarly, CAR cells produce CXCL12 in association with CXCR4 signaling essentially for HSC maintenance (modified from [12]).
A group of de Borros supports this hypothesis by showing that the 3D spheroid of noninduced and one week osteo-induce bone marrow stromal cell (active osteoblasts) formed an informative microenvironment that control migration, lodgment, and proliferation of HSCs [63]. Bone marrow endosteal cells, particularly, osteoblast-enriched ALCAM+Sca-1− cells promoted LT-reconstitution activity of HSCs via the upregulation of genes related in homing and cell adhesion [64]. In addition, HSCs were found to adhere with spindle-shaped N-cadherin+ osteoblastic (SNO) cells which are a subpopulation of osteoblasts [65]. BMP receptor type IA mutant mice have been shown to increase in the number of SNO cells that correlated to an increase in HSC number [65]. Consistently, green fluorescent protein-positive (GFP+) HSCs derived from Col2.3-GFP+ transgenic mouse were found to attach to SNO cells but not all GFP+ HSCs were in contact with SNO cells showing that N-cadherin− component might be the other niche for HSCs [54]. Cumulatively, osteoblasts and SNO cells are suggested as the niche for hematopoietic stem and progenitor cells where this microenvironment termed “Endosteal niche.”
Some observations have suggested that another niche, vascular niche, might involve in HSC maintenance within the bone marrow. Studies in osteoblast depletion demonstrated that there was a loss of B lymphopoiesis but not immediately loss of HSC number [66, 67] and few bone-marrow HSCs (CD150+CD48−CD41−lineage−) were localized to the endosteum [68]. Mice model defected in osteoblast function conferred no changes in LT-reconstitution function of HSCs [69]. Additionally, the loss of N-cadherin did not any effect on HSC maintenance and hematopoiesis [70]. Most HSCs in the bone marrow have been observed to reside in the sinusoid, where fenestrated endothelium persists and allows blood flow for an exchange of blood cells and small molecules. Taken together, the vascular niche is suggested as the other niche for HSC maintenance [68]. Bone-marrow endothelial cells have been proposed to play a role in HSC controlling within vascular niche. Primary CD31+ microvascular endothelial cells can restore hematopoiesis in mice when they receive bone-marrow lethal doses of irradiation [71]. Study by a group of Salter shows a consistent observation that endothelial progenitor cells injected in total body irradiated mice can stimulate HSC reconstitution and hematologic recovery [72]. Furthermore, selective activation of Akt in endothelial cells produced angiocrine factors mediated in the reconstitution, expansion, and maintenance of HSCs [73]. Nonetheless, constitutively activation of Akt, a binding ligand of phosphoinositide 3 in the phosphoinositide 3-kinase pathway, impaired engraftment ability and preferable generated leukemia in mice [74]. Sinusoidal endothelial cells are essential for engraftment of hematopoietic stem and progenitor cells (HSPCs) and restoration of hematopoiesis after myeloablation [75]. Angiocrine factors, such as Notch ligands, released by endothelial cells in vivo contributed to the replenishment of the LT-HSC pool and resulted in reconstitution of hematopoiesis [76]. Altogether, vascular niche containing endothelial cells is suggested as the major HSC pool and maintenance conferring proliferation and differentiation selection.
Additionally, Sugiyama and colleagues demonstrated that reticular cells located around the sinusoid endothelium could produce stromal cell-derived factor 1 (SDF-1, aka CXCL12) mediated in HSC niche [77]. These cells have been named CXCL12 abundant reticular cells (CAR cells). This study showed that almost all HSCs were found in contact with CAR cells and all HSCs allocated at endosteum were also found to be in contact with CAR cells, suggesting that these cells play a crucial role in HSC niches by homing HSCs in both vascular and endosteal niches [77]. CXCL12/CXCR4 signaling is essential in maintaining the HSC pool, development of B cells and plasmacytoid dendritic cells [78–81]. Moreover, short-term ablation of CAR cells resulted in the impairment of adipogenic and osteogenic differentiation. Thus, CAR cells are suggested as the adipo-osteogenic progenitors [82]. Study in CAR cell-depleted mice demonstrated that HSCs were reduced in number and cell size, which were more quiescent and highly expressed early myeloid selector genes [82]. CAR cells were suggested to coincide with CD146+ stromal progenitors that express CXCL12 and Ang-1. CD146+ cells could generate osteoblast that form bone and could function as skeletal progenitor cells [83]. Taken together, CAR cells provide or generate the hematopoietic microenvironment that link to the hematopoietic regulation in both vascular and endosteal niches.
4. Hierarchy of Human Hematopoiesis
Based on the study of molecular marker expression by flow cytometry analysis has led the identification of each blood cell subpopulations in terms of their biology and potential when combined with other functional assays. As a result, schematic demonstration of hematopoietic hierarchy has been proposed (Figure 4) [13]. The origin of all blood cell in hematopoietic system is believed to be derived from HSCs that contain self-renewal capacity and give rise to multipotent progenitors (MPPs) which lose self-renewal potential but remain fully differentiate into all multilineages. MPPs further give rise to oligopotent progenitors which are common lymphoid and myeloid progenitors (CLPs and CMPs, resp.). All these oligopotent progenitors differentiate into their restricted lineage commitment: (1) CMPs advance to megakaryocyte/erythrocyte progenitors (MEPs), granulocyte/macrophage progenitors (GMPs), and dendritic cell (DC) progenitors, (2) CLPs give rise to T cell progenitors, B cell progenitors, NK cell progenitors and DC progenitors. Notably, DC progenitors (CD8α+ DC, CD8α− DC, and plasmacytoid DC) could be derived from both CMPs and CLPs [84–86].
Hierarchy of hematopoiesis. The phenotypic cell surface marker of each population of mouse and human blood system is shown (modified from [13]). In the mouse hematopoiesis system, MPPs omit CMPs which directly give rise to MEPs unlink in the human system (dash line). CLP, common lymphoid progenitor; CMP, common myeloid progenitor; DC, dendritic cell; EP, erythrocyte progenitor; GMP, granulocyte/macrophage progenitor; GP, granulocyte progenitor; HSC, hematopoietic stem cell; MacP, macrophage progenitor; MEP, megakaryocyte/erythrocyte progenitor; MkP, megakaryocyte progenitor; NK, natural killer; Lin, lineage markers.
Among the isolation and characterization of HSCs and progenitors, CD34 molecule is the first widely chosen for the study by several researchers. CD34 is comprised in the CD34 family of cell-surface transmembrane proteins together with podocalyxin and endoglycan [87–89]. CD34 expression on blood cells is about 0.1–4.9% in human cord blood, bone marrow, and peripheral blood [90–92]. The first candidate human HSCs was a population of cells expressing CD34+CD90+(Thy-1)Lin− which could give rise to T and B lymphocytes and myeloerythroid activities in both in vitro and in vivo human fetal thymus transplanted into SCID mice while some subset of CD34−, CD90−, Lin− lacked of multipotent progenitors [93]. Further isolation of HSCs was based on the expression of CD38 [94, 95] and CD45RA [96]. This data could be concluded that Lin−CD34+CD38−CD90+CD45RA− population enriches for human HSCs and the candidate human MPP fraction of multipotency with an incomplete self-renewal capacity is enriched in Lin−CD34+CD38−CD90−CD45RA− population [97]. However, recently observation using HSC xenograft assay in NOD-SCID-IL2Rgc−/− (NSG) mice has shown that both Lin−CD34+CD38−CD90− CD45RA− and Lin−CD34+CD38−CD90+CD45RA− contain LT repopulating activity in secondary recipients with different frequency [98]. In addition, CD49f (integrin α6) marker has been shown as a specific HSC marker within Lin−CD34+CD38−CD45RA− population which as single-sorted HSC is highly efficient in generating long-term multilineage grafts while the loss of CD49f expression results in the absence of long-term grafts [98]. Furthermore, Rhodamine-123 marker (efflux of the mitochondrial dye) is added to enrich for HSCs where high Rho efflux (Rholo)Lin−CD34+CD38−CD90+CD45RA− can also repopulate all blood lineages in secondary recipients [98]. Taken together, these results demonstrate that human HSCs are enriched in the Lin−CD34+CD38−CD90+/−CD45RA−Rholo population of hematopoietic cells (Figure 4).
5. Signaling Pathways in Self-Renewal and Maintenance of HSCs
The balance that controls between self-renewal and differentiation (or cell fate decision) of HSCs in the bone marrow is mediated by several factors. There are a number of animal models promoting the concept that the niches inside bone marrow provide the maintenance and regulation of HSCs by some microenvironmental-dependent signals. Most HSCs are in quiescent state (i.e., in G0/G1 phase of the cell cycle) [99], however, when the hematopoietic cells disturbance occurs, hematopoiesis system will respond by shutting down or turning on the regulators mediated in the regulations. Several pathways have been studied in relation to that circumstance which are SDF-1 (CXCL12)/CXCR4 signaling, BMP signaling, Mpl/Thrombopoietin (TPO) signaling, Tie2/Ang-1 signaling, hedgehog and Notch signaling, as well as Wingless (Wnt) signaling.
5.1. SDF-1 (CXCL12 )/CXCR4 Signaling Pathway
Stromal cell-derived factor 1 (SDF-1) is constitutively expressed in several organs including lung, liver, skin, and bone marrow [100]. SDF-1 belongs to α-chemokines that functions as chemoattractant for both committed and primitive hematopoietic progenitors and regulates embryonic development including organ homeostasis [100]. There are two main splicing forms that have been identified, SDF-1α and SDF-1β, which ubiquitously expressed with highest levels detected in liver, pancreas, and spleen [101]. Additionally, another variant form, SDF-γ, has been characterized in the nervous system [102]. Subsequently, SDF-1δ, SDF-1ε, and SDF-ϕ have been identified with highly expression in pancreases and lower levels detection in heart, kidney, liver, and spleen [103]. SDF-1 counteracts with its cognate receptor, CXCR4 that expresses widely in numerous tissues including hematopoietic and endothelial cells to stimulate the physiological processes. SDF-1/CXCR4 signaling plays a critical role during embryonic development by regulating B-cell lymphopoiesis, myelopoiesis in bone marrow and heart ventricular septum formation [104–106]. In addition, SDF-1 has been shown to be mediated in the recruitment of endothelial progenitor cells (EPCs) from the bone marrow through a CXCR4 dependent mechanism suggesting the functional role in vasculogenesis in which EPCs could form blood vessels [107]. A number of observations demonstrated that there was an increase in SDF-1 expression the ischemic sites [108, 109]. More evidence demonstrated that locally injection of SDF-1 augmented vasculogenesis and subsequently contributed to ischemic neovascularization in vivo by promoting EPC recruitment in ischemic tissues [110]. Recently, Liu and colleagues have shown that signal of SDF-1/CXCR4 together with CXCR7 can increase the mobilization and paracrine actions of mesenchymal stem cells (MSCs) ischemic kidneys under hypoxia condition [111]. Moreover, SDF-1/CXCR4 not only plays a role in HSC maintenance but also regulates HSC attachment within the niche. The mechanism mediated in this regulation was found to be activated through matrix metalloproteinase-9 that mediated in the releasing of soluble Kit-ligand [112]. Inactivation or deletion of CXCR4 in mice resulted in HSC pool reduction and hyperproliferation responsive to HSC defections [77, 78]. Tzeng and colleagues also confirmed the role of SDF-1 in HSC maintenance by demonstrating that a conditional SDF-1-deficient mice conferred an impairment in HSC quiescence and endosteal niche localization [113].
5.2. BMP Signaling Pathway
Bone morphogenic proteins (BMPs) are a group of growth factors that belongs to a TGF-β family member [114]. BMPs are mainly produced by osteoclasts in HSC niche [115]. During embryogenesis, BMP-4 regulates hematopoietic lineage commitment from mesodermal cell, while HSC number and function within bone marrow niche is controlled by Bmp-4 during adult life [116, 117]. Knowledge of BMP signaling and receptor related adult HSC within bone marrow has been studied in a small number and is elusive. BMP signaling impairment displayed an increase in the niche size, leading to the enhancement in the number of HSCs [65]. Differential response of HSC to soluble BMPs observed by a group of Bhatia showed that higher concentrations of BMP-2, BMP-4 and BMP-7 maintained human CB HSCs in vitro while at lower concentrations of BMP-4-induced proliferation and differentiation of HSCs [118].
5.3. c-Mpl/TPO Signaling Pathway
c-Mpl and its ligand, thrombopoietin (TPO), are known to regulate megakaryopoiesis [119]. c-Mpl receptor is expressed mainly on HSCs, with a lesser extent on megakaryocytic progenitors, megakaryocytes and platelets [120]. Various tissues expressing c-Mpl are mediated in hematopoiesis, including bone marrow, spleen, and fetal liver [14]. Based on the crystallographic EPO receptor study and its analogy to the TPO receptor have led to the postulation that TPO initiates the signal transduction by binding to the c-Mpl at the distal part, which in turn a homodimer of c-Mpl becomes active [15]. Consequently, Janus kinase 2 (JAK2) can phosphorylate tyrosine residues within the receptor itself which at least two tyrosine residues, Tyr625 and Tyr630, are phosphorylated on c-Mpl [15, 122], thereby stimulating the downstream cascade STATs, PI3K, the mitogen-activated protein kinases (MAPKs), and extracellular signal regulated kinases-1 and -2 (Figure 5) [123, 124]. c-Mpl/TPO signaling involved in postnatal steady-state HSC maintenance and cell-cycle progression at the endosteal surface [125, 126]. Mpl-expressed LT-HSCs were found in correlation to cell cycle quiescence and that was closely associated with TPO-producing osteoblastic cells in the bone marrow [125]. Additionally, the inhibitory adaptor protein Lnk was suggested as a negative regulator of JAK2 in HSCs following TPO stimulation, in which HSC quiescence and self-renewal controls were predominantly through Mpl [127]. Therefore, TPO/Mpl/JAK2/Lnk pathway can be concluded as a gatekeeper for HSC quiescence. Recently, TPO knock-in RAG2−/−γc−/− mice has been shown to improve human engraftment in the bone marrow and maintenance of HSPCs pool by serial transplantation [128]. Taken together, TPO has an important function in maintenance and self-renewal of HSCs.
c-Mpl/TPO signaling pathway. TPO signals to its receptor, c-Mpl, and induces the downstream signaling cascades: STATs, PI3K, MAPKs, and extracellular signal regulated kinases-1 and -2 (modified from [14, 15]).
5.4. Tie2/Ang-1 Signaling
Angiopoietin-1 (Ang-1) is the ligand of Tie2, a receptor tyrosine kinase, which expresses predominantly on osteoblastic cells in endosteum [59] and in MSCs [83]. Interaction of Tie2 with its ligand, Ang-1, resulted in tightly adhesion of HSCs to the niche and become more quiescence [59]. Moreover, Ang-1 conferred the maintenance of LT-HSCs while Ang-2 did not antagonize the effects of Ang-1 on gene expression, Akt (aka protein B) phosphorylation [129].
5.5. Hedgehog Signaling Pathway
Hedgehog (Hh) is proposed as a negative regulator of the HSC quiescence [130]. Hh ligand binds to the transmembrane receptor Patched (Ptc) and subsequently allows the signaling function of a second transmembrane protein, Smoothened (Smo), essentially for the Hh signal to be active. Trowbridge and colleagues demonstrated that constitutive activation of the Hh signaling pathway in Ptc heterozygous (Ptc-1+/−) mice resulted in induction of cell cycling and expansion of primitive bone marrow hematopoietic cells [130]. To support this hypothesis, deletion of Smo in the in utero of transgenic mice was performed and the result demonstrated that there was an impaired stem cell self-renewal and the inhibition in engraftment activity of HSCs [131]. Furthermore, the common downstream positive effector of Hg signaling, Gli1, has been shown to play a critical role in normal and stress hematopoiesis [132]. Nonetheless, the discrepancies on Hg role in hematopoiesis were shown in some studies claiming that the conditional loss of Smo within adult HSCs is dispensable for hematopoiesis [133, 134]. These conflicts might be due to the difference of the mice model and conditional system used to impair Hg signaling.
5.6. Notch Signaling Pathway
Notch signaling plays a key role in several fundamental functions including proliferation, differentiation and cell fate decision [135, 136]. Four notch receptors (Notch 1–4) and five ligands (Jagged1-2 and Delta-like 1, 3, and 4) have been identified in mammals [137]. Cells expressing Notch ligands or engineered immobilized Notch ligands could maintain or enhance HSC self-renewal in the culture [138, 139]. Some investigations demonstrated that there were an impaired HSCs differentiation both in vitro [140, 141] and in vivo [139, 141] studies following interaction of Notch receptors and Notch ligands. Transcription factor act upstream of the Notch signaling cascade, Hes2, was shown to be essential in HSCs formation in zebrafish embryos when hes2 expression was knockdown, whereas HSC formation could be rescued by the activation of Notch signal [142]. One study showed that an increase in in vitro maintenance of hematopoietic functions and repopulating potential on osteoblasts and Lineage−Sca-1+CD117+ (LSK) cells coculture was mediated by the up-regulation of Notch signal (Notch2, Jagged1 and 2, Delta1 and 4, Hes1 and 5, and Deltex) [58]. Taken together, these studies support the role of Notch signaling mediated in HSC hematopoiesis and maintenance. In the contrary, some investigations proposed that Notch signaling was not important for HSC self-renewal and maintenance [143, 144]. Inactivation of Notch1 and Jagged1 in bone marrow progenitors and bone marrow stroma, respectively, did not impair HSC maintenance and reconstitution [144]. The inhibition of Notch1–4 signaling via a developed dominant-negative Mastermind-like1 construct was transfected into LSK and demonstrated similar result of LT reconstitution in bone marrow compared to LSK control, except for T-cells [143]. Nevertheless, the study by Kim and colleague explored the important of Notch in normal hematopoiesis [145]. Mind bomb (Mib)-1, which regulates the endocytosis of Notch ligands and activation, was inactivated in mice leading to myeloproliferative disease (MPD). Surprisingly, when transplanted with wild-type bone marrow cells into the Mib1-null microenvironment, it results in a de novo MPD. The MPD progression was suppressed by transplantable Notch activating cells, suggesting that MPD develops from the nonhematopoietic microenvironmental cells with defective Notch signaling. Therefore, Notch signaling is indeed required for normal hematopoiesis. Santaguida and colleague developed JunB-deficient mice which resulted in impairment of Notch and transforming growth factor-β (TGF-β) signaling, in part via the transcriptional regulation of Hes1 [146]. This study showed an increase in LT-HSCs proliferation and differentiation without impairing their self-renewal in vivo, suggesting that LT-HSC proliferation rate is not exclusively compelling to self-renewal activity and maintenance of HSC in the BM niches.
5.7. Wnt Signaling Pathway
Notch signaling is involved in the cross-talk with other pathways particularly Wnt signaling not only in hematopoiesis [147] but also in other cellular development [136, 148–151]. In addition, Wnt signaling pathway is mediated in the regulation of stem cell fate and maintenance of mouse ESCs and human ESCs in undifferentiated state [152, 153]. There are at least two independent pathway comprised in Wnt signaling: canonical Wnt and noncanonical Wnt signaling pathways. The canonical Wnt signal interacts with Frizzled (Fz) receptors and single-pass co-receptors LDL-receptor-related proteins 5 and 6 (LRP 5 and 6). The Fz protein contains a conserved motif, a cysteine rich domain (CRD) located on the extracellular domain that binds to multiple Wnts with a high affinity (Figure 6) [154]. Specifically, Dishevelled (DVL) is phosphorylated by casein kinase Iε (CKIε), which then binds typically to FRAT and confers the assembly between Fz to DVL (Fz-DVL complex) and LRP5/6 to AXIN and FRAT (LRP5/6-AXIN-FRAT complex) [155, 156]. After that, β-catenin is stabilized and released from phosphorylation by CKIα and GSK3β. Then, β-catenin forms the complex with T-cell factor/lymphoid enhancer binding factor (TCF/LEF) family transcription factors and also with Legless family docking proteins (BCL9 and BCL9L) associated with PYGO family coactivators for stabilization and nuclear accumulation [157–159]. Typically, the downstream effectors for transcriptional activation target genes are FGF20, DKK1, WISP1, MYC, and CCND1 [160–163]. In the absence of Wnt, β-catenin is destabilized by phosphorylation of CKIα and glycogen synthase kinase 3β (GSK 3β), which then resulted in a formation of a destruction complex facilitating by Axin (β-catenin-APC-AXIN) that is polyubiquitinated by βTRCP1 or βTRCP2 complex for the degradation by proteasome [16, 159].
A canonical Wnt signaling pathway. In the presence of Wnt, the signals are transduced through Frizzled family receptors and LRP5/LRP6 coreceptor to the β-catenin signaling cascade which then stabilize hypophosphorylated β-catenin and interact with TCF/LEF, Legless and PYGO for target gene activations. MARK and CKIε are the positive regulators of canonical Wnt pathway, while APC, AXIN1, AXIN2, CKIα, NKD1, NKD2, βTRCP1, βTRCP2, and ANKRD6 are negative regulators. In the absence of Wnt, β-catenin-forming complex with AXIN and APC is phosphorylates, leading to be a target for ubiquitination and degradation by proteasome (adapted from [16]).
In the second pathway, “noncanonical Wnt signal” exerts the independent β-catenin signaling. The Wnt subfamily members, for example, Wnt5a binds to the Frizzled receptor, stimulates downstream intracellular signaling, resulting in an increase in intracellular Ca2+, and then activates protein kinase C and calmodulin-dependent kinase [159]. The cross-talk between Notch and Wnt signaling pathways was found in the stabilizing β-catenin on bone-marrow stroma cells that promoted maintaining and self-renewal of HSCs [164]. Moreover, the induction of Jagged1 and delta-like 1 was observed in Wnt/β-catenin-activated bone-marrow stroma or in bone-marrow stroma cultured with Wnt3a-conditioned medium [164]. Mice lacking Wnt3a resulted in prenatal death [165]. Moreover, Wnt3a deficiency reduced the number of HSCs in fetal liver and impaired the repopulating activity in vivo [165]. However, the exact role of Wnt signaling pathway in regulation of HSCs remains a controversy. Some studies demonstrated that constitutive activation of Wnt/β-catenin in transgenic mice resulting in the multilineage differentiation block and loss of repopulating stem cell activity due to the induction of quiescent stem cells entering into cell cycle and arresting their differentiation [166, 167]. In contrast to previous works, the administration of an inhibitor of GSK-3βin vivo displayed the enhancement in the recovery of hematopoietic cells for neutrophil and megakaryocytic lineages as well as primitive LSK cell population together with the upregulation of Wnt, Notch, and Hedgehog genes [168].
Furthermore, inhibition of Wnt signaling in HSCs by overexpression of the paninhibitor of canonical Wnt signaling, Dickkopf1 (Dkk1), resulted in the induction of cell cycling and reduction in repopulating ability in transplanted induction mice [169]. When the inhibitor of GSK-3β, 6-bromoindirubin 3′-oxime was used to treat CB-CD34+ cells, cell cycle progression was delayed including promoted engraftment of ex vivo-expanded HSCs [170]. Cumulatively, these studies suggest the positive regulatory role of Wnt/β-catenin signal on the proliferative or repopulating activity of HSCs. 12/15-lipoxygenase-mediated unsaturated fatty acid metabolism has been implicated in canonical Wnt-related signaling in the maintenance of LT-HSC quiescence and number [171]. Taken together, the canonical Wnt signal is mediated in the regulation of HSC function by maintaining quiescence and balance in proliferation.
6. Concluding Remarks
HSCs have been studied extensively for HSC source, hematopoiesis, biological functions, and signaling pathways related to the maintenance and regulation of HSCs. Advance researches such as imaging system clearly provide useful information on tracking the HSC origin, pool, and transplantation outcome in the mouse models. The observation of molecular mechanisms downstream the signaling cascade of self-renewing and proliferation of HSCs will also provide the knowledge through the new discovery in the treatment of diseases including the development in the performing a large scale preparation of HSCs for clinical transplantation. In addition, the signaling pathways will also provide understanding insight into the cancer stem cells which are now challenging scientists to explore their possible strategy for the treatments.
SeraY.LaRueA. C.MoussaO.MehrotraM.DuncanJ. D.WilliamsC. R.NishimotoE.SchulteB. A.WatsonP. M.WatsonD. K.OgawaM.Hematopoietic stem cell origin of adipocytes20093791108.e41120.e42-s2.0-6854911115010.1016/j.exphem.2009.06.008PozzobonM.BolliniS.IopL.De GaspariP.ChiavegatoA.RossiC. A.GiulianiS.LeonF. F.ElvassoreN.SartoreS.De CoppiP.Human bone marrow-derived CD133+ cells delivered to a collagen patch on cryoinjured rat heart promote angiogenesis and arteriogenesis20101910124712602-s2.0-7865086103410.3727/096368910X505864ElkhafifN.El BazH.HammamO.HassanS.SalahF.MansourW.MansyS.YehiaH.ZakiA.MagdyR.CD133+ human umbilical cord blood stem cells enhance angiogenesis in experimental chronic hepatic fibrosis2011119166752-s2.0-7865012441510.1111/j.1600-0463.2010.02693.xEbiharaY.MasuyaM.LaRueA. C.FlemingP. A.ViscontiR. P.MinamiguchiH.DrakeC. J.OgawaM.Hematopoietic origins of fibroblasts: II. In vitro studies of fibroblasts, CFU-F, and fibrocytes20063422192292-s2.0-3184445474610.1016/j.exphem.2005.10.008KhuranaS.MukhopadhyayA.In vitro transdifferentiation of adult hematopoietic stem cells: an alternative source of engraftable hepatocytes200849699810072-s2.0-5554909511210.1016/j.jhep.2008.05.019SellamuthuS.ManikandanR.ThiagarajanR.BabuG.DineshD.PrabhuD.ArulvasuC.In vitro trans-differentiation of human umbilical cord derived hematopoietic stem cells into hepatocyte like cells using combination of growth factors for cell based therapy20116332592682-s2.0-7995591185010.1007/s10616-011-9337-xDominiciM.PritchardC.GarlitsJ. E.HofmannT. J.PersonsD. A.HorwitzE. M.Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation20041013211761117662-s2.0-414314430910.1073/pnas.0404626101MehrotraM.RosolM.OgawaM.LaRueA. C.Amelioration of a mouse model of osteogenesis imperfecta with hematopoietic stem cell transplantation: microcomputed tomography studies20103875936022-s2.0-7795349977410.1016/j.exphem.2010.04.008MinamiguchiH.IshikawaF.FlemingP. A.YangS.DrakeC. J.WingardJ. R.OgawaM.Transplanted human cord blood cells generate amylase-producing pancreatic acinar cells in engrafted mice2008362e30e352-s2.0-4554908685110.1097/MPA.0b013e3181584656CoskunS.HirschiK. K.Establishment and regulation of the HSC niche: roles of osteoblastic and vascular compartments20109042292422-s2.0-7865047989610.1002/bdrc.20194GekasC.RhodesK. E.van HandelB.ChhabraA.UenoM.MikkolaH. K. A.Hematopoietic stem cell development in the placenta2010546-7108910982-s2.0-7795485775010.1387/ijdb.103070cgNagasawaT.OmatsuY.SugiyamaT.Control of hematopoietic stem cells by the bone marrow stromal niche: the role of reticular cells20113273153202-s2.0-7995981083410.1016/j.it.2011.03.009SeitaJ.WeissmanI. L.Hematopoietic stem cell: self-renewal versus differentiation2010266406532-s2.0-7875158293910.1002/wsbm.86ChouF. S.MulloyJ. C.The thrombopoietin/MPL pathway in hematopoiesis and leukemogenesis20111126149114982-s2.0-7995446452510.1002/jcb.23089GeddisA. E.Megakaryopoiesis20104732122192-s2.0-7795390325710.1053/j.seminhematol.2010.03.001KatohM.KatohM.WNT signaling pathway and stem cell signaling network20071314404240452-s2.0-3454710731910.1158/1078-0432.CCR-06-2316JacobsonL. O.SimmonsE. L.MarksE. K.EldredgeJ. H.Recovery from radiation injury195111329405105112-s2.0-0037819808LorenzE.UphoffD.REIDT. R.SheltonE.Modification of irradiation injury in mice and guinea pigs by bone marrow injections19511211972012-s2.0-0000448725TillJ. E.McE. A.A direct measurement of the radiation sensitivity of normal mouse bone marrow cells19611421322210.1667/RRXX28.1SiminovitchL.MccullochE. A.TillJ. E.The distribution of colony-forming cells among spleen colonies1963623273362-s2.0-0000461656SchofieldR.The relationship between the spleen colony-forming cell and the haemopoietic stem cell. A hypothesis197841-27252-s2.0-0018102359MooreM. A.MetcalfD.Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo19701832792962-s2.0-0014744817ZeiglerB. M.SugiyamaD.ChenM.GuoY.DownsK. M.SpeckN. A.The allantois and chorion, when isolated before circulation or chorio-allantoic fusion, have hematopoietic potential200613321418341922-s2.0-3375151022010.1242/dev.02596MedvinskyA.DzierzakE.Definitive hematopoiesis is autonomously initiated by the AGM region19968668979062-s2.0-003059534110.1016/S0092-8674(00)80165-8MüllerA. M.MedvinskyA.StrouboulisJ.GrosveldF.DzierzakE.Development of hematopoietic stem cell activity in the mouse embryo1994142913012-s2.0-0028467947de BruijnM. F. T. R.SpeckN. A.PeetersM. C. E.DzierzakE.Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo20001911246524742-s2.0-0034214284HuyhnA.DommerguesM.IzacB.CroisilleL.KatzA.VainchenkerW.CoulombelL.Characterization of hematopoietic progenitors from human yolk sacs and embryos19958612447444852-s2.0-0028789694LabastieM. C.CortésF.RoméoP. H.DulacC.PéaultB.Molecular identity of hematopoietic precursor cells emerging in the human embryo19989210362436352-s2.0-0032533914TavianM.CoulombelL.LutonD.ClementeH. S.Dieterlen-LièvreF.PéaultB.Aorta-associated CD34+ hematopoietic cells in the early human embryo199687167722-s2.0-0030051968TavianM.RobinC.CoulombelL.PéaultB.The human embryo, but not its yolk sac, generates lympho-myeloid stem cells: mapping multipotent hematopoietic cell fate in intraembryonic mesoderm20011534874952-s2.0-003480254210.1016/S1074-7613(01)00193-5ChenM. J.YokomizoT.ZeiglerB. M.DzierzakE.SpeckN. A.Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter200945772318878912-s2.0-6014910001010.1038/nature07619de BruijnM. F. T. R.MaX.RobinC.OttersbachK.SanchezM. J.DzierzakE.Hematopoietic stem cells localize to the endothelial cell layer in the midgestation mouse aorta20021656736832-s2.0-003628564710.1016/S1074-7613(02)00313-8TaylorE.TaoudiS.MedvinskyA.Hematopoietic stem cell activity in the aorta-gonad-mesonephros region enhances after mid-day 11 of mouse development2010546-7105510602-s2.0-7795484153610.1387/ijdb.103152etBárcenaA.KapidzicM.MuenchM. O.GormleyM.ScottM. A.WeierJ. F.FerlatteC.FisherS. J.The human placenta is a hematopoietic organ during the embryonic and fetal periods of development2009327124332-s2.0-5964912087010.1016/j.ydbio.2008.11.017RobinC.BollerotK.MendesS.HaakE.CrisanM.CerisoliF.LauwI.KaimakisP.JornaR.VermeulenM.KayserM.van der LindenR.ImaniradP.VerstegenM.Nawaz-YousafH.PapazianN.SteegersE.CupedoT.DzierzakE.Human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development2009543853952-s2.0-7034930850010.1016/j.stem.2009.08.020CrossJ. C.How to make a placenta: mechanisms of trophoblast cell differentiation in mice—a review200526supplement 1S3S92-s2.0-1704437124210.1016/j.placenta.2005.01.015GeorgiadesP.Fergyson-SmithA. C.BurtonG. J.Comparative developmental anatomy of the murine and human definitive placentae20022313192-s2.0-003636576210.1053/plac.2001.0738CoxB.KotlyarM.EvangelouA. I.IgnatchenkoV.IgnatchenkoA.WhiteleyK.JurisicaI.AdamsonS. L.RossantJ.KislingerT.Comparative systems biology of human and mouse as a tool to guide the modeling of human placental pathology20095, article 2792-s2.0-6765082520310.1038/msb.2009.37RossantJ.CrossJ. C.Placental development: lessons from mouse mutants2001275385482-s2.0-003540653010.1038/35080570CorbelC.SalaünJ.Belo-DiabangouayaP.Dieterlen-LièvreF.Hematopoietic potential of the pre-fusion allantois200730124784882-s2.0-3384626186510.1016/j.ydbio.2006.08.069RhodesK. E.GekasC.WangY.LuxC. T.FrancisC. S.ChanD. N.ConwayS.OrkinS. H.YoderM. C.MikkolaH. K. A.The emergence of hematopoietic stem cells isInitiated in the placental vasculature in the absence of circulation2008232522632-s2.0-3914910056410.1016/j.stem.2008.01.001MurrayP. D. F.The development in vitro of the blood of the early chick embryo1932111773497521JaffredoT.GautierR.EichmannA.Dieterlen-LièvreF.Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny199812522457545832-s2.0-0031696447NishikawaS. I.NishikawaS.KawamotoH.YoshidaH.KizumotoM.KataokaH.KatsuraY.In vitro generation of lymphohematopoietic cells from endothelial cells purified from murine embryos1998867617692-s2.0-1774441604810.1016/S1074-7613(00)80581-6EilkenH. M.NishikawaS. I.SchroederT.Continuous single-cell imaging of blood generation from haemogenic endothelium200945772318969002-s2.0-6014910275110.1038/nature07760BoissetJ. C.Van CappellenW.Andrieu-SolerC.GaljartN.DzierzakE.RobinC.In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium201046472851161202-s2.0-7794991144110.1038/nature08764OberlinE.HafnyB. E.Petit-CocaultL.SouyriM.Definitive human and mouse hematopoiesis originates from the embryonic endothelium: a new class of HSCs based on VE-cadherin expression2010546-7116511732-s2.0-7795484231010.1387/ijdb.103121eoAraT.TokoyodaK.SugiyamaT.EgawaT.KawabataK.NagasawaT.Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny20031922572672-s2.0-004243205410.1016/S1074-7613(03)00201-2GuoY.HangocG.BianH.PelusL. M.BroxmeyerH. E.SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells2005239132413322-s2.0-2714452114710.1634/stemcells.2005-0085XieT.SpradlingA. C.decapentaplegic is essential for the maintenance and division of germline stem cells in the Drosophila ovary19989422512602-s2.0-003256316510.1016/S0092-8674(00)81424-5NilssonS. K.SimmonsP. J.BertoncelloI.Hemopoietic stem cell engraftment20063421231292-s2.0-3184445338910.1016/j.exphem.2005.08.006BasuS.RayN. T.AtkinsonS. J.BroxmeyerH. E.Protein phosphatase 2A plays an important role in stromal cell-derived factor-1/CXC chemokine ligand 12-mediated migration and adhesion of CD34+ cells20071795307530852-s2.0-36148969861Lo CelsoC.FlemingH. E.WuJ. W.ZhaoC. X.Miake-LyeS.FujisakiJ.CôtéD.RoweD. W.LinC. P.ScaddenD. T.Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche2009457722592962-s2.0-5814926026910.1038/nature07434XieY.YinT.WiegraebeW.HeX. C.MillerD.StarkD.PerkoK.AlexanderR.SchwartzJ.GrindleyJ. C.ParkJ.HaugJ. S.WunderlichJ. P.LiH.ZhangS.JohnsonT.FeldmanR. A.LiL.Detection of functional haematopoietic stem cell niche using real-time imaging20094577225971012-s2.0-5814925028710.1038/nature07639JungY.SongJ.ShiozawaY.WangJ.WangZ.WilliamsB.HavensA.SchneiderA.GeC.FranceschiR. T.McCauleyL. K.KrebsbachP. H.TaichmanR. S.Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche2008268204220512-s2.0-5334910577710.1634/stemcells.2008-0149CalviL. M.AdamsG. B.WeibrechtK. W.WeberJ. M.OlsonD. P.KnightM. C.MartinR. P.SchipaniE.DivietiP.BringhurstF. R.MilnerL. A.KronenbergH. M.ScaddenD. T.Osteoblastic cells regulate the haematopoietic stem cell niche200342569608418462-s2.0-024226852410.1038/nature02040WeberJ. M.ForsytheS. R.ChristiansonC. A.FrischB. J.GigliottiB. J.JordanC. T.MilnerL. A.GuzmanM. L.CalviL. M.Parathyroid hormone stimulates expression of the Notch ligand Jagged1 in osteoblastic cells20063934854932-s2.0-3374665258310.1016/j.bone.2006.03.002ChittetiB. R.ChengY. H.PoteatB.Rodriguez-RodriguezS.GoebelW. S.CarlessoN.KacenaM. A.SrourE. F.Impact of interactions of cellular components of the bone marrow microenvironment on hematopoietic stem and progenitor cell function201011516323932482-s2.0-7795145577810.1182/blood-2009-09-246173AraiF.HiraoA.OhmuraM.SatoH.MatsuokaS.TakuboK.ItoK.KohG. Y.SudaT.Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche200411821491612-s2.0-324266914510.1016/j.cell.2004.07.004TaichmanR. S.Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche20051057263126392-s2.0-1594437783510.1182/blood-2004-06-2480StierS.KoY.ForkertR.LutzC.NeuhausT.GrünewaldE.ChengT.DombkowskiD.CalviL. M.RittlingS. R.ScaddenD. T.Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size200520111178117912-s2.0-2124447278010.1084/jem.20041992StaudtN. D.AicherW. K.KalbacherH.StevanovicS.CarmonaA. K.BogyoM.KleinG.Cathepsin X is secreted by human osteoblasts, digests CXCL-12 and impairs adhesion of hematopoietic stem and progenitor cells to osteoblasts2010959145214602-s2.0-7795683235710.3324/haematol.2009.018671de BarrosA. P. D. N.TakiyaC. M.GarzoniL. R.Leal-FerreiraM. L.DutraH. S.ChiariniL. B.MeirellesM. N.BorojevicR.RossiM. I. D.Osteoblasts and bone marrow mesenchymal stromal cells control hematopoietic stem cell migration and proliferation in 3D in vitro model2010522-s2.0-7794937995810.1371/journal.pone.0009093e9093NakamuraY.AraiF.IwasakiH.HosokawaK.KobayashiI.GomeiY.MatsumotoY.YoshiharaH.SudaT.Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells20101169142214322-s2.0-7795657495810.1182/blood-2009-08-239194ZhangJ.NiuC.YeL.HuangH.HeX.TongW. G.RossJ.HaugJ.JohnsonT.FengJ. Q.HarrisS.WiedemannL. M.MishinaY.LiL.Identification of the haematopoietic stem cell niche and control of the niche size200342569608368412-s2.0-024236322510.1038/nature02041ZhuJ.GarrettR.JungY.Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cell20071099370637122-s2.0-3434739553910.1182/blood-2007-05-091447VisnjicD.KalajzicZ.RoweD. W.KatavicV.LorenzoJ.AguilaH. L.Hematopoiesis is severely altered in mice with an induced osteoblast deficiency20041039325832642-s2.0-194245730810.1182/blood-2003-11-4011KielM. J.RadiceG. L.MorrisonS. J.Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance2007122042172-s2.0-3454767060410.1016/j.stem.2007.06.001MaY. D.ParkC.ZhaoH.OduroK. A.TuX.LongF.AllenP. M.TeitelbaumS. L.ChoiK.Defects in osteoblast function but no changes in long-term repopulating potential of hematopoietic stem cells in a mouse chronic inflammatory arthritis model200911420440244102-s2.0-7334911620710.1182/blood-2008-12-196311KielM. J.AcarM.RadiceG. L.MorrisonS. J.Hematopoietic stem cells do not depend on N-cadherin to regulate their maintenance2009421701792-s2.0-5924909435810.1016/j.stem.2008.10.005LiB.BaileyA. S.JiangS.LiuB.GoldmanD. C.FlemingW. H.Endothelial cells mediate the regeneration of hematopoietic stem cells20104117242-s2.0-7314909429910.1016/j.scr.2009.08.001SalterA. B.MeadowsS. K.MuramotoG. G.HimburgH.DoanP.DaherP.RussellL.ChenB.ChaoN. J.ChuteJ. P.Endothelial progenitor cell infusion induces hematopoietic stem cell reconstitution in vivo20091139210421072-s2.0-6184909255610.1182/blood-2008-06-162941KobayashiH.ButlerJ. M.O'DonnellR.KobayashiM.DingB. S.BonnerB.ChiuV. K.NolanD. J.ShidoK.BenjaminL.RafiiS.Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells20101211104610562-s2.0-7814928074010.1038/ncb2108KharasM. G.OkabeR.GanisJ. J.GozoM.KhandanT.PaktinatM.GillilandD. G.GritsmanK.Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice20101157140614152-s2.0-7794990065010.1182/blood-2009-06-229443HooperA. T.ButlerJ. M.NolanD. J.KranzA.IidaK.KobayashiM.KoppH. G.ShidoK.PetitI.YangerK.JamesD.WitteL.ZhuZ.WuY.PytowskiB.RosenwaksZ.MittalV.SatoT. N.RafiiS.Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells2009432632742-s2.0-6084913878710.1016/j.stem.2009.01.006ButlerJ. M.NolanD. J.VertesE. L.Varnum-FinneyB.KobayashiH.HooperA. T.SeandelM.ShidoK.WhiteI. A.KobayashiM.WitteL.MayC.ShawberC.KimuraY.KitajewskiJ.RosenwaksZ.BernsteinI. D.RafiiS.Endothelial cells are essential for the self-renewal and repopulation of notch-dependent hematopoietic stem cells2010632512642-s2.0-7744912192310.1016/j.stem.2010.02.001SugiyamaT.KoharaH.NodaM.NagasawaT.Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches20062569779882-s2.0-3384544593910.1016/j.immuni.2006.10.016NieY.HanY. C.ZouY. R.CXCR4 is required for the quiescence of primitive hematopoietic cells200820547777832-s2.0-4224910357410.1084/jem.20072513NodaM.OmatsuY.SugiyamaT.OishiS.FujiiN.NagasawaT.CXCL12-CXCR4 chemokine signaling is essential for NK-cell development in adult mice201111724514582-s2.0-7875169463010.1182/blood-2010-04-277897KoharaH.OmatsuY.SugiyamaT.NodaM.FujiiN.NagasawaT.Development of plasmacytoid dendritic cells in bone marrow stromal cell niches requires CXCL12-CXCR4 chemokine signaling200711013415341602-s2.0-3964909700010.1182/blood-2007-04-084210NagasawaT.Microenvironmental niches in the bone marrow required for B-cell development2006621071162-s2.0-3364484508110.1038/nri1780OmatsuY.SugiyamaT.KoharaH.KondohG.FujiiN.KohnoK.NagasawaT.The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche20103333873992-s2.0-7795702016710.1016/j.immuni.2010.08.017SacchettiB.FunariA.MichienziS.Di CesareS.PiersantiS.SaggioI.TagliaficoE.FerrariS.RobeyP. G.RiminucciM.BiancoP.Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment200713123243362-s2.0-3534892168210.1016/j.cell.2007.08.025TraverD.AkashiK.ManzM.MeradM.MiyamotoT.EnglemanE. G.WeissmanI. L.Development of CD8α-positive dendritic cells from a common myeloid progenitor20002905499215221542-s2.0-003467038510.1126/science.290.5499.2152ManzM. G.TraverD.AkashiK.MeradM.MiyamotoT.EnglemanE. G.WeissmanI. L.Dendritic cell development from common myeloid progenitors20019381671742-s2.0-0034937916ManzM. G.TraverD.MiyamotoT.WeissmanI. L.AkashiK.Dendritic cell potentials of early lymphoid and myeloid progenitors20019711333333412-s2.0-003538377510.1182/blood.V97.11.3333DoyonnasR.KershawD. B.DuhmeC.MerkensH.ChelliahS.GrafT.McNagnyK. M.Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin2001194113272-s2.0-003579648710.1084/jem.194.1.13SassettiC.Van ZanteA.RosenS. D.Identification of endoglycan, a member of the CD34/podocalyxin family of sialomucins200027512900190102-s2.0-003470877610.1074/jbc.275.12.9001SassettiC.TangemannK.SingerM. S.KershawD. B.RosenS. D.Identification of Podocalyxin-like protein as a high endothelial venule ligand for L-selectin: parallels to CD34199818712196519752-s2.0-003252656510.1084/jem.187.12.1965PrankeP.HendrikxJ.DebnathG.AlespeitiG.RubinsteinP.NardiN.VisserJ.Immunophenotype of hematopoietic stem cells from placental/umbilical cord blood after culture20053812177517892-s2.0-30544446970HossleJ. P.SegerR. A.SteinhoffD.Gene therapy of hematopoietic stem cells: strategies for improvement200217387922-s2.0-0036613395KrauseD. S.FacklerM. J.CivinC. I.MayW. S.CD34: structure, biology, and clinical utility19968711132-s2.0-0030028585BaumC. M.WeissmanI. L.TsukamotoA. S.BuckleA. M.PeaultB.Isolation of a candidate human hematopoietic stem-cell population1992897280428082-s2.0-0026576937BhatiaM.WangJ. C. Y.KappU.BonnetD.DickJ. E.Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice19979410532053252-s2.0-003091135810.1073/pnas.94.10.5320HaoQ. L.ShahA. J.ThiemannF. T.SmogorzewskaE. M.CrooksG. M.A functional comparison of CD34+CD38- cells in cord blood and bone marrow19958610374537532-s2.0-0028818775MayaniH.DragowskaW.LansdorpP. M.Characterization of functionally distinct subpopulations of CD34+ cord blood cells in serum-free long-term cultures supplemented with hematopoietic cytokines1993829266426722-s2.0-0027453455MajetiR.ParkC. Y.WeissmanI. L.Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood2007166356452-s2.0-3674909840010.1016/j.stem.2007.10.001NottaF.DoulatovS.LaurentiE.PoepplA.JurisicaI.DickJ. E.Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment201133360392182212-s2.0-7996010688010.1126/science.1201219FlemingW. H.AlpernE. J.UchidaN.IkutaK.SpangrudeG. J.WeissmanI. L.Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells199312248979022-s2.0-0027185511RatajczakM. Z.Zuba-SurmaE.KuciaM.RecaR.WojakowskiW.RatajczakJ.The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis20062011191519242-s2.0-3375029400910.1038/sj.leu.2404357ShirozuM.NakanoT.InazawaJ.TashiroK.TadaH.ShinoharaT.HonjoT.Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene19952834955002-s2.0-002909952110.1006/geno.1995.1180GleichmannM.GillenC.CzardybonM.BosseF.Greiner-PetterR.AuerJ.MüllerH. W.Cloning and characterization of SDF-1γ, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system2000126185718662-s2.0-003411876810.1046/j.1460-9568.2000.00048.xYuL.CecilJ.PengS. B.SchrementiJ.KovacevicS.PaulD.SuE. W.WangJ.Identification and expression of novel isoforms of human stromal cell-derived factor 120063741-21741792-s2.0-3364674990010.1016/j.gene.2006.02.001BalabanianK.LaganeB.InfantinoS.ChowK. Y. C.HarriagueJ.MoeppsB.Arenzana-SeisdedosF.ThelenM.BachelerieF.The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes20052804235760357662-s2.0-2744444314210.1074/jbc.M508234200MoeppsB.BraunM.KnopfleK.Characterization of a Xenopus laevis CXC chemokine receptor 4: implications for hematopoietic cell development in the vertebrate embryo2000301029242934BraunM.WunderlinM.SpiethK.KnöchelW.GierschikP.MoeppsB.Xenopus laevis stromal cell-derived factor 1: conservation of structure and function during vertebrate development20021685234023472-s2.0-0036499179ZhengH.FuG.DaiT.HuangH.Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1α/CXCR4 via PI3K/Akt/eNOS signal transduction pathway20075032742802-s2.0-3454871086110.1097/FJC.0b013e318093ec8fCeradiniD. J.KulkarniA. R.CallaghanM. J.TepperO. M.BastidasN.KleinmanM. E.CaplaJ. M.GalianoR. D.LevineJ. P.GurtnerG. C.Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-120041088588642-s2.0-404318406510.1038/nm1075YangY.TangG.YanJ.ParkB.HoffmanA.TieG.WangR.MessinaL. M.Cellular and molecular mechanism regulating blood flow recovery in acute versus gradual femoral artery occlusion are distinct in the mouse2008486154615582-s2.0-5794909713310.1016/j.jvs.2008.07.063YamaguchiJ. I.KusanoK. F.MasuoO.KawamotoA.SilverM.MurasawaS.Bosch-MarceM.MasudaH.LosordoD. W.IsnerJ. M.AsaharaT.Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization20031079132213282-s2.0-003743229310.1161/01.CIR.0000055313.77510.22LiuH.LiuS.LiY.The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury201274e34608HeissigB.HattoriK.DiasS.FriedrichM.FerrisB.HackettN. R.CrystalR. G.BesmerP.LydenD.MooreM. A. S.WerbZ.RafiiS.Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand200210956256372-s2.0-1844438945110.1016/S0092-8674(02)00754-7TzengY. S.LiH.KangY. L.ChenW. G.ChengW.LaiD. M.Loss of Cxcl12/Sdf-1 in adult mice decreases the quiescent state of hematopoietic stem/progenitor cells and alters the pattern of hematopoietic regeneration after myelosuppression201111724294392-s2.0-7875155901610.1182/blood-2010-01-266833ReddiA. H.ReddiA.Bone morphogenetic proteins (BMPs): from morphogens to metabologens2009205-63413422-s2.0-7144910862310.1016/j.cytogfr.2009.10.015GarimellaR.TagueS. E.ZhangJ.BelibiF.NaharN.SunB. H.InsognaK.WangJ.AndersonH. C.Expression and synthesis of bone morphogenetic proteins by osteoclasts: a possible path to anabolic bone remodeling20085665695772-s2.0-4394911910910.1369/jhc.2008.950394GoldmanD. C.BaileyA. S.PfaffleD. L.Al MasriA.ChristianJ. L.FlemingW. H.BMP4 regulates the hematopoietic stem cell niche200911420439344012-s2.0-7334912346110.1182/blood-2009-02-206433DurandC.RobinC.BollerotK.BaronM. H.OttersbachK.DzierzakE.Embryonic stromal clones reveal developmental regulators of definitive hematopoietic stem cells20071045220838208432-s2.0-3804913873810.1073/pnas.0706923105BhatiaM.BonnetD.WuD.MurdochB.WranaJ.GallacherL.DickJ. E.Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells19991897113911482-s2.0-003352606710.1084/jem.189.7.1139BroudyV. C.KaushanskyK.Thrombopoietin, the c-mpl ligand, is a major regulator of platelet production19955757197252-s2.0-0029020445DebiliN.WendlingF.CosmanD.TiteuxM.FlorindoC.Dusanter-FourtI.SchooleyK.MethiaN.CharonM.NadorR.BettaiebA.VainchenkerW.The MpI receptor is expressed in the megakaryocytic lineage from late progenitors to platelets19958523914012-s2.0-0028985426LivnahO.SturaE. A.MiddletonS. A.JohnsonD. L.JolliffeL. K.WilsonI. A.Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation199928354049879902-s2.0-003354825910.1126/science.283.5404.987DrachmanJ. G.KaushanskyK.Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain1997946235023552-s2.0-003090024710.1073/pnas.94.6.2350WitthuhnB. A.QuelleF. W.SilvennoinenO.YiT.TangB.MiuraO.IhleJ. N.JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin19937422272362-s2.0-002732748410.1016/0092-8674(93)90414-LTortolaniP. J.JohnstonJ. A.BaconC. M.McVicarD. W.ShimosakaA.LinnekinD.LongoD. L.O'SheaJ. J.Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase, JAK219958512344434512-s2.0-0029051429YoshiharaH.AraiF.HosokawaK.HagiwaraT.TakuboK.NakamuraY.GomeiY.IwasakiH.MatsuokaS.MiyamotoK.MiyazakiH.TakahashiT.SudaT.Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche2007166856972-s2.0-3674899935110.1016/j.stem.2007.10.020QianH.Buza-VidasN.HylandC. D.JensenC. T.AntonchukJ.MånssonR.ThorenL. A.EkblomM.AlexanderW. S.JacobsenS. E. W.Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells2007166716842-s2.0-3674900104310.1016/j.stem.2007.10.008BersenevA.WuC.BalcerekJ.TongW.Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK220081188283228442-s2.0-4874908413010.1172/JCI35808RongvauxA.WillingerT.TakizawaH.RathinamC.AuerbachW.MurphyA. J.ValenzuelaD. M.YancopoulosG. D.EynonE. E.StevensS.ManzM. G.FlavellR. A.Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo20111086237823832-s2.0-7995229474910.1073/pnas.1019524108GomeiY.NakamuraY.YoshiharaH.HosokawaK.IwasakiH.SudaT.AraiF.Functional differences between two Tie2 ligands, angiopoietin-1 and -2, in regulation of adult bone marrow hematopoietic stem cells201038282.e189.e12-s2.0-7394913117010.1016/j.exphem.2009.11.007TrowbridgeJ. J.ScottM. P.BhatiaM.Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration20061033814134141392-s2.0-3374900085510.1073/pnas.0604568103ZhaoC.ChenA.JamiesonC. H.FereshtehM.AbrahamssonA.BlumJ.KwonH. Y.KimJ.ChuteJ. P.RizzieriD.MunchhofM.VanArsdaleT.BeachyP. A.ReyaT.Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia200945872397767792-s2.0-6474909186710.1038/nature07737MerchantA.JosephG.WangQ.BrennanS.MatsuiW.Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors201011512239123962-s2.0-7795062425510.1182/blood-2009-09-241703HofmannI.StoverE. H.CullenD. E.MaoJ.MorganK. J.LeeB. H.KharasM. G.MillerP. G.CornejoM. G.OkabeR.ArmstrongS. A.GhilardiN.GouldS.de SauvageF. J.McMahonA. P.GillilandD. G.Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis2009465595672-s2.0-6604908512510.1016/j.stem.2009.03.016GaoJ.GravesS.KochU.LiuS.JankovicV.BuonamiciS.El AndaloussiA.NimerS. D.KeeB. L.TaichmanR.RadtkeF.AifantisI.Hedgehog signaling is dispensable for adult hematopoietic stem cell function2009465485582-s2.0-6604910251210.1016/j.stem.2009.03.015Artavanis-TsakonasS.RandM. D.LakeR. J.Notch signaling: cell fate control and signal integration in development199928454157707762-s2.0-003361752210.1126/science.284.5415.770LinG. L.HankensonK. D.Integration of BMP, Wnt, and Notch signaling pathways in osteoblast differentiation20111121234913501RanganathanP.WeaverK. L.CapobiancoA. J.Notch signalling in solid tumours: a little bit of everything but not all the time20111153383512-s2.0-7995546063610.1038/nrc3035OhishiK.Varnum-FinneyB.BernsteinI. D.Delta-1 enhances marrow and thymus repopulating ability of human CD34+CD38- cord blood cells20021108116511742-s2.0-003680217410.1172/JCI200216167Varnum-FinneyB.HalaszL. M.SunM.GridleyT.RadtkeF.BernsteinI. D.Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells20111213120712162-s2.0-7995221721010.1172/JCI43868Varnum-FinneyB.Brashem-SteinC.BernsteinI. D.Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting ability20031015178417892-s2.0-003737083410.1182/blood-2002-06-1862StierS.ChengT.DombkowskiD.CarlessoN.ScaddenD. T.Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome2002997236923782-s2.0-003652998910.1182/blood.V99.7.2369RowlinsonJ. M.GeringM.Hey2 acts upstream of Notch in hematopoietic stem cell specification in zebrafish embryos201011612204620562-s2.0-7795718955110.1182/blood-2009-11-252635MaillardI.KochU.DumortierA.ShestovaO.XuL.SaiH.ProssS. E.AsterJ. C.BhandoolaA.RadtkeF.PearW. S.Canonical notch signaling is dispensable for theMaintenance of adult hematopoietic stem cells2008243563662-s2.0-4144908945710.1016/j.stem.2008.02.011ManciniS. J. C.ManteiN.DumortierA.SuterU.MacDonaldH. R.RadtkeF.Jagged1-dependent Notch signaling is dispensable for hematopoietic stem cell self-renewal and differentiation20051056234023422-s2.0-1524434622610.1182/blood-2004-08-3207KimY. W.KooB. K.JeongH. W.YoonM. J.SongR.ShinJ.JeongD. C.KimS. H.KongY. Y.Defective Notch activation in microenvironment leads to myeloproliferative disease200811212462846382-s2.0-5814938832910.1182/blood-2008-03-148999SantaguidaM.SchepersK.KingB.SabnisA. J.ForsbergE. C.AttemaJ. L.BraunB. S.PasseguéE.JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal20091543413522-s2.0-6324909556210.1016/j.ccr.2009.02.016ClementsW. K.KimA. D.OngK. G.MooreJ. C.LawsonN. D.TraverD.A somitic Wnt16/Notch pathway specifies haematopoietic stem cells201147473502202242-s2.0-7995829004210.1038/nature10107ChalamalasettyR. B.DuntyW. C.Jr.BirisK. K.AjimaR.IacovinoM.BeisawA.FeigenbaumL.ChapmanD. L.YoonJ. K.KybaM.YamaguchiT. P.The Wnt3a/β-catenin target gene Mesogenin1 controls the segmentation clock by activating a Notch signalling program201121, article 3902-s2.0-7996033358510.1038/ncomms1381HanS.DziedzicN.GadueP.KellerG. M.Gouon-EvansV.An endothelial cell niche induces hepatic specification through dual repression of Wnt and notch signaling20112922172282-s2.0-7995212026210.1002/stem.576PeterI. S.DavidsonE. H.A gene regulatory network controlling the embryonic specification of endoderm201147473536356392-s2.0-7995985368110.1038/nature10100KimD. W.LeeJ. S.YoonE. S.LeeB. I.ParkS. H.DhongE. S.Influence of human adipose-derived stromal cells on Wnt signaling in organotypic skin culture20112226946982-s2.0-7995389763310.1097/SCS.0b013e3182077fa2SatoN.MeijerL.SkaltsounisL.GreengardP.BrivanlouA. H.Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor200410155632-s2.0-124226792710.1038/nm979WollP. S.MorrisJ. K.PainschabM. S.MarcusR. K.KohnA. D.BiecheleT. L.MoonR. T.KaufmanD. S.Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells200811111221312-s2.0-3804914465110.1182/blood-2007-04-084186WuC. H.NusseR.Ligand receptor interactions in the Wnt signaling pathway in Drosophila20022774441762417692-s2.0-003683012610.1074/jbc.M207850200WongH. C.BourdelasA.KraussA.LeeH. J.ShaoY.WuD.MlodzikM.ShiD. L.ZhengJ.Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled2003125125112602-s2.0-034441347710.1016/S1097-2765(03)00427-1TolwinskiN. S.WehrliM.RivesA.ErdenizN.DiNardoS.WieschausE.Wg/Wnt signal can be transmitted through arrow/LRP5,6 and axin independently of Zw3/Gsk3β activity2003434074182-s2.0-003734395210.1016/S1534-5807(03)00063-7KrampsT.PeterO.BrunnerE.NellenD.FroeschB.ChatterjeeS.MuroneM.ZülligS.BaslerK.Wnt/Wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear β-catenin-TCF complex2002109147602-s2.0-003702358410.1016/S0092-8674(02)00679-7KatohM.KatohM.Identification and characterization of human BCL9L gene and mouse Bcl9l gene in silico20031246436492-s2.0-2842563838MillerJ. R.HockingA. M.BrownJ. D.MoonR. T.Mechanism and function of signal transduction by the Wnt/B-catenin and Wnt/Ca2+ pathways19991855786078722-s2.0-0033590172ChamorroM. N.SchwartzD. R.VonicaA.BrivanlouA. H.ChoK. R.VarmusH. E.FGF-20 and DKK1 are transcriptional targets of β-catenin and FGF-20 is implicated in cancer and development200524173842-s2.0-1324429910910.1038/sj.emboj.7600460PennicaD.SwansonT. A.WelshJ. W.RoyM. A.LawrenceD. A.LeeJ.BrushJ.TaneyhillL. A.DeuelB.LewM.WatanabeC.CohenR. L.MelhemM. F.FinleyG. G.QuirkeP.GoddardA. D.HillanK. J.GurneyA. L.BotsteinD.LevineA. J.WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors1998952514717147222-s2.0-1304429542710.1073/pnas.95.25.14717HeT. C.SparksA. B.RagoC.HermekingH.ZawelL.Da CostaL. T.MorinP. J.VogelsteinB.KinzlerK. W.Identification of c-MYC as a target of the APC pathway19982815382150915122-s2.0-003248343910.1126/science.281.5382.1509TetsuO.McCormickF.β-catenin regulates expression of cyclin D1 in colon carcinoma cells199939867264224262-s2.0-003311980110.1038/18884KimJ. A.KangY. J.ParkG.KimM.ParkY. O.KimH.LeemS. H.ChuI. S.LeeJ. S.JhoE. H.OhI. H.Identification of a stroma-mediated Wnt/β-catenin signal promoting self-renewal of hematopoietic stem cells in the stem cell niche2009276131813292-s2.0-6764959532610.1002/stem.52LuisT. C.WeerkampF.NaberB. A. E.BaertM. R. M.De HaasE. F. E.NikolicT.HeuvelmansS.De KrijgerR. R.Van DongenJ. J. M.StaalF. J. T.Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation200911335465542-s2.0-6024910179910.1182/blood-2008-06-163774SchellerM.HuelskenJ.RosenbauerF.TaketoM. M.BirchmeierW.TenenD. G.LeutzA.Hematopoietic stem cell and multilineage defects generated by constitutive β-catenin activation2006710103710472-s2.0-3374885950910.1038/ni1387KirstetterP.AndersonK.PorseB. T.JacobsenS. E. W.NerlovC.Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block2006710104810562-s2.0-3374885063610.1038/ni1381TrowbridgeJ. J.XenocostasA.MoonR. T.BhatiaM.Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation200612189982-s2.0-3004444425110.1038/nm1339FlemingH. E.JanzenV.Lo CelsoC.GuoJ.LeahyK. M.KronenbergH. M.ScaddenD. T.Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo2008232742832-s2.0-3974917839010.1016/j.stem.2008.01.003KoK.-H.HolmesT.PalladinettiP.SongE.NordonR.O'BrienT. A.DolnikovA.GSK-3β inhibition promotes engraftment of ex vivo-expanded hematopoietic stem cells and modulates gene expression20112911081182-s2.0-7995183293210.1002/stem.551KinderM.WeiC.ShelatS. G.KunduM.ZhaoL.BlairI. A.PuréE.Hematopoietic stem cell function requires 12/15-lipoxygenase-dependent fatty acid metabolism201011524501250222-s2.0-7795466626910.1182/blood-2009-09-243139